← FDA Drug Approvals (Drugs@FDA)

PYRIDOSTIGMINE BROMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVITIUM PHARMA · Approved 2019-03-08

Drug application

FDA Application #

ANDA211694

Application type

Abbreviated New Drug Application (Generic)

Brand name

PYRIDOSTIGMINE BROMIDE

Generic name

PYRIDOSTIGMINE BROMIDE ORAL

Active ingredients

PYRIDOSTIGMINE BROMIDE

Dosage form

SYRUP

Route

ORAL

Marketing status

Prescription

Sponsor

NOVITIUM PHARMA

Manufacturer

Novitium Pharma LLC

First approval

2019-03-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown